Geert Jan Mulder
Geert-Jan Mulder has made 67 investments in companies such as: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems, Borean Pharma, Roche Glycart, NovoGI, Oxyrane UK, OMEICOS Therapeutics, Inflazome, Amakem, Pulmologix, Ardana Bioscience, CoviCept Therapeutics, Rigontec, FlowMedica, Oxular, NeRRe Therapeutics, Hookipa Pharma, NorthSea Therapeutics, SANIFIT, PneumRx, Gotham Therapeutics, Catalym, Insmed, Mitralign, Prilenia, KaNDy Therapeutics, Ario Pharma, Cardoz, CircuLite, BioVex, Cytheris, Bluebird Bio, Pieris AG, UniQure, CellNovo, Akarna Therapeutics, Escalier Biosciences, Azafaros, Enterprise Therapeutics, Bioceros, Replimune Group, Exosome Diagnostics, Acorda Therapeutics, Dyne Therapeutics, gIcare Pharma, Amphista Therapeutics, Milestone Pharmaceuticals, Dezima Pharma, Fovea Pharmaceuticals, Inversago Pharma, Gyroscope Therapeutics, New Amsterdam Pharma, Autonomic Technologies, Xention, Achilles Therapeutics, arGEN-X, Curetis, ACADIA Pharmaceuticals, Allecra Therapeutics, PanGenetics, Promedior, Transave, Argos Therapeutics, enGene, Prexton Therapeutics.Location of Geert-Jan Mulder is Naarden, The Netherlands.
The free version of Angel Match provides limited data for Geert-Jan Mulder. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.Geert-Jan Mulder is a Managing Partner and he his investment types are: Venture Capital.Geert-Jan Mulder focuses investing in industries such as: Biopharma, Biotechnology, Health Diagnostics, Life Science, Medical, Therapeutics, Genetics, Health Care, Pharmaceutical, Wellness.
A short brief about investor: